Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin for Prevention of Type 2 Hepatorenal Syndrome
NCT02489864Phase 4Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2015
- Primary completion
- Jul 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terlipressin in hepatorenal syndrome type 2, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
terlipressin
03
Conditions
hepatorenal syndrome type 2
Beyond the preview
Go deeper on NCT02489864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02489864.